+34 620 10 75 37info@nanbiosis.com

Singular

Singular

You are here : Home / Singular (Page 5)

U7-S11. Contact angle

Contact angle

The Contact angle service of U7 is specialized in the characterization of surface-liquid interactions at the macro-scale. One can measure contact angle of different liquids and determine the surface free energy of different surfaces under investigation, as well as the wettability properties of different surfaces or different coatings.

Customer benefits

Our Contact angle service benefits from being part of a bioengineering-specialized research centre, providing wide knowledge in the treatment of different surfaces to tailor their properties according to the final bio-application. We offer custom services, assuring close and direct interaction with the client, to meet conclusive results and high-quality needs.

Target customer

Our target customers are researchers in the field of bioengineering or R&D departments of biotech companies which want to test, characterize, or compare different substrates, materials or prototypes.

Additional information


Contact angle measurement of diiodomethane on silicon wafer.

• Read More

U3-S04. Peptide libraries (Remote) OUTSTANDING

Peptide libraries.

• Read More

U3-S03. Special amino acids for peptidomimemtics synthesis (Remote) OUTSTANDING

Special amino acids for peptidomimemtics synthesis (Remote) OUTSTANDING

– Synthesis of N-alkyl amino acids and other special amino acids
– Synthesis of peptoids (N-alkylglycine oligomers).
– Synthesis of β-peptide, γ- peptides, β,γ-peptides and α,β-peptides
– Synthesis of peptidomimetics
– Synthesis of hybrid-heterocycle- peptides

Customer benefits

  • Extensive experience in the synthesis of peptide oligomers from non-natural amino acids such as β-peptides, γ-peptides, β,γ-peptides and α,β-peptides.
  • Experience with peptides and peptide mimetics in solid phase and in solution.
  • Development of various strategies for large-scale production (hundreds of mg) of peptidomimetics.

Target customer

  • Research groups (drug delivery, molecular biology, pharmacology, nanotechnology, biotechnology)
  • Companies (biotech and pharma companies).

References

  • Hybrid cyclobutane/proline-containing peptidomimetics: the conformational constraint influences their cell-penetration ability. Illa, Ona ; Ospina, Jimena; Sanchez-Aparicio, Jose-Emilio; Pulido, Ximena ; Abengozar, Maria Angeles; Gaztelumendi, Nerea; Carbajo, Daniel; Nogues, Carme; Rivas, Luis ; Marechal, Jean-Didier; Royo, Miriam ; Ortuño, Rosa M. International Journal of Molecular Sciences (2021), 22, 5092.
  • Chiral cyclobutane-containing cell-penetrating peptides as selective vectors for anti-Leishmania drug delivery systems. Illa, Ona ; Olivares, Jose-Antonio; Gaztelumendi, Nerea; Martinez-Castro, Laura; Ospina, Jimena; Abengozar, Maria-Angeles; Sciortino, Giuseppe ; Marechal, Jean-Didier; Nogues, Carme; Royo, Miriam; Rivas, Luis; Ortuno, Rosa M. International Journal of Molecular Sciences (2020), 21, 7502.
  • A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D1 and D2 dopamine receptors. Molero, Anabel; Vendrell, Marc; Bonaventura, Jordi; Zachmann, Julian; Lopez, Laura; Pardo, Leonardo; Lluis, Carme; Cortes, Antoni; Albericio, Fernando; Casado, Vicent; Royo, Miriam. European Journal of Medicinal Chemistry (2015), 97, 173-180.
  • Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents. Cavalli, Silvia; Carbajo, Daniel; Acosta, Milena; Lope-Piedrafita, Silvia; Candiota, Ana Paula; Arus, Carles; Royo, Miriam; Albericio, Fernando. Chemical Communications (2012), 48, 5322-5324.

• Read More

U2-S08. Inmunochemical methods development (Remote) OUTSTANDING

CAbS offers personalized development of immunoassays. Antibodies and other necessary immunoreagents can be synthesized.

The development of the immunoassay includes different stages:

  1. Design of the immunoassay format, sample matrix, the sensibility and the working range. Identification of necessary reagents and their conditions to obtain optimal results.
  2. Development Phase. Establishing assay parameters, for example the detection limit and working range. Evaluation of the effects of the matrix on the assay. Reproducibility study.
  3. Assay validation. Evaluation of the stability and robustness of the reagents. Measurement of inter and intra-assay reproducibility, precision and specificity. Validation with blind samples. Assay platforms: ELISA, microarrays with different formats based on the detection of individual analytes or multiplexed assays.
• Read More

U2-S07. Antibody purification (Remote) OUTSTANDING

The purification of the antibodies includes the isolation of the antibody from the serum (polyclonal antibodies) or culture supernatant from hybridoma cell lines (monoclonal antibodies). The services offers previous advise on the different possibilities for purification according to the needs of the user.

The methods of purification that we offer vary from crude methods (precipitation of the proteins from the sample including any antibody present) to general purification (purification by affinity of certain classes of antibodies without taking account of the specificity to the antigen) to specific (purification by affinity of the antibodies which join specifically to a definite antigen).

  • Ammonium sulfate precipitation
  • Protein A, protein G affinity purification
  • Specific antigen affinity purification
• Read More

U2-S06. Hybridoma cell culture antibody production (Remote) OUTSTANDING

Hybridoma cell culture in ultralow serum medium. We use CELLine™  Bioreactor Technologys to produce monoclonal antibodies.

• Read More

U2-S05. Monoclonal Antibody development (Remote) OUTSTANDING

The mAb development contains the following phases:

  1. Immunisation of mice, titre determination in the antiserum.
  2. Cultivation of the myeloma cell line, cell fusion, selection in HAT medium and screening.
  3. Cloning , screening and cultivation of positive cultures. Further cloning and obtaining stable clones.
  4. Expansion and Cryo conservation of the selected clones. Delivery of cell culture supernatants and frozen hybridoma cells.
• Read More

U2-S04. Polyclonal Antibody Production (Remote) OUTSTANDING

The service has a standard immunization protocol that includes monthly inoculations with Freund adjuvant during a period of 4 months. This protocol can be adapted to final project objective.

To determine the progress of the immune response, a bleed is taken after 10 days after the second immunization to obtain antiserum and the titer is determined through ELISA.

Among the controls is included obtaining preimmune serum from the animals obtained from the blood previously to the first injection. At the end of the process 50-70 mL of hyperimmune serum is obtained per animal from final production bleed.

• Read More

U2-S03. Preparation of Bioconjugates and Molecular Probes (Remote) OUTSTANDING

Protein and hapten conjugation services with different types of molecules such as: Enzymes, Fluorophores, Biotin, KLH, BSA, gold particles, magnetic particles, nanotubes…

Preparation of antibody fragments.

• Read More

U2-S02. Hapten synthesis (Remote) OUTSTANDING

Selection of suitable leading structures for antigen preparation, hapten synthesis, hapten modification and derivation.

• Read More